Special Issue "Nutraceuticals and Botanicals: Bioactive Molecules and Therapeutic Properties for Human Health"
A special issue of Pharmaceuticals (ISSN 1424-8247).
Deadline for manuscript submissions: closed (31 March 2017).
Interests: phytochemicals; HPLC; food chemistry; herbal preparations; chromatography; antioxidants; analytical strategies
Special Issues and Collections in MDPI journals
Special Issue in Foods: Screening, Identification, and Quantification of Nutritional Components and Phytochemicals in Foodstuffs
Special Issue in Sustainability: Green Extraction Technologies and Analytical Strategies for Sustainable Food By-Products Valorisation: Food-Health Relationships in Sustainable Agro-Food Systems
Special Issue in Sustainability: Food Security and Sustainable Rural Development: Exploiting Potential Functional Foods with High Health-Impact as an Example of Biodiversity Integration and Conservation
Special Issue in Nutrients: The Benefits of Bioactive Compounds from Natural Resources and Relative Antioxidant and Health-Promoting Properties
Special Issue in AppliedChem: Advanced Analytical Strategies for Identification and Quantification of Bioactive Compounds in Natural Products
Special Issue in Foods: Chromatographic Fingerprint as a Tool for Food Security and Phytochemical Characterization: Bioactive Molecules and Health-Promoting Properties in Traditional Food and Beverage
Nutraceuticals and botanicals are biologically active phytochemicals that possess health benefits. These may be delivered to the consumer as natural medicines, herbal preparations, and functional foods. These products are likely to play a vital role in human health and longevity. The consumption of these products by the most of the people is usually without a medical prescription and/or supervision: increasing use of these products has also led to concerns about their actual safety. Not only do consumers increasingly take charge of their health, but the scientific information and understanding of the beneficial health effects of bioactive substances have improved. In recent years, the industry has suffered a setback in its growth, due to certain instances of quality failures and/or adverse health effects. This situation has created an urgency for increased regulatory oversight and for monitoring the products at different stages of manufacturing for quality, safety, and integrity. Recent improvements in the identification, characterization, and standardization of raw materials, coupled with screening by human cell line and gene expression-directed fractionation, are expected to improve the development of new nutraceuticals and drugs. These will afford an important benefit to the rapidly emerging alternative, complementary, and integrated healthcare practices. It is also hoped that the nutraceutical/herbal industries and regulatory agencies will work together to prevent the ultimate cost of new drug development from becoming prohibitive.
The proposed topics include, but are not limited to:
- biomarkers and medical properties;
- nutraceuticals and new functional foods;
- herbal preparations and natural medicines;
- botanicals and medicinal plants;
- antioxidants and healthy-properties;
- benefits, adverse effects and drug interactions of herbal medicines;
- quality control and regulatory guidelines;
- marketing and economic evaluation;
- bioactive substances and phytocomplexes;
- analytical strategies for bioactive compound identification and quantification;
- in vivo and in vitro bioactivity of botanicals.
Dr. Dario Donno
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Plant Phytochemicals on Drug Development in Pharmaceuticals (6 articles)
- Medicinal Plants 2020 in Pharmaceuticals (26 articles)
- Bioactive Compounds from Plants and Foods with Pharmaceutical Interest in Pharmaceuticals (28 articles)
- Applications of Liquid Chromatography in Analysis of Pharmaceuticals and Natural Products in Pharmaceuticals (11 articles)
- Medicinal Plants and Natural Compounds for Modulation of Neuroendocrine-Immune System and Potential Use in Ageing-Related Disorders in Pharmaceuticals (4 articles)
- Anticancer Compounds in Medicinal Plants in Pharmaceuticals (10 articles)